NCT04154059

Brief Summary

The main objective of this trial is To evaluate the effect of an ankle and foot muscle strengthening program on pain, analgesic consumption, functionality, and lower limb biomechanics during gait in individuals with knee osteoarthritis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Jan 2020

Longer than P75 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 6, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

January 27, 2020

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2020

Completed
3.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 4, 2023

Completed
Last Updated

April 2, 2025

Status Verified

March 1, 2025

Enrollment Period

1 month

First QC Date

October 31, 2019

Last Update Submit

March 28, 2025

Conditions

Keywords

RehabilitationArthrosisTherapeutic exercisesFeet

Outcome Measures

Primary Outcomes (1)

  • Change from baseline The WOMAC (Western Ontario and McMaster Universities) Pain Subscale at 8 and 16 weeks.

    The WOMAC pain subscale consists of five questions (Likert Scale) relating to the patient's pain in everyday situations. The Likert Scale version used for all WOMAC items are: none, mild, moderate, severe, and extreme. The sum of all items of pain subscale ranges from 0 to 20. Higher scores indicate worse pain.

    Baseline, 8 weeks and 16 weeks.

Secondary Outcomes (11)

  • Change from baseline WOMAC (Western Ontario and McMaster Universities) Stiffness Subscale at 8 and 16 weeks.

    Baseline, 8 weeks and 16 weeks.

  • Change from baseline WOMAC (Western Ontario and McMaster Universities) Physical Function Subscale at 8 and 16 weeks.

    Baseline, 8 weeks and 16 weeks.

  • Change from baseline WOMAC (Western Ontario and McMaster Universities) Total Score at 8 and 16 weeks

    Baseline, 8 weeks and 16 weeks.

  • 30-second Chair Stand Test

    Baseline, 8 weeks and 16 weeks.

  • 9-step Stair Climb Test

    Baseline, 8 weeks and 16 weeks.

  • +6 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

Patients will receive a physical therapy intervention three times per week, for 8 weeks.

Other: Intervention Group

Control Group

NO INTERVENTION

Patients will not receive any exercise treatment but they will keep their recommended clinical treatment.

Interventions

Patients will receive a physical therapy intervention for strengthening, stretching and functional training of ankle and foot.

Also known as: Foot and ankle kinesiotherapy
Intervention Group

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Knee osteoarthritis (KOA) based on clinical and radiological criteria of American College of Reumathology;
  • KOA (Grade II and III - Radiological classification of Kellgreen and Laurence) in medial compartment of knee;
  • Knee pain between 30 and 80 on the visual analogue scale;
  • BMI \< 35 kg/m2.

You may not qualify if:

  • KOA isolated (Grade II and III - Radiological classification of Kellgreen and Laurence) in lateral compartment of knee;
  • Lower limb strength training (3 times per week);
  • Wear minimalist shoes for at least 6 hours a day and 5 days a week;
  • Physical therapy in the previous 3 months;
  • Having received steroid injections and hyaluronic acid intra-articular knee in previous periods of three and six months respectively;
  • Previous history of surgery on knees, ankles and hips in the last 2 years;
  • Neurological disease;
  • Inflammatory arthritis (eg. rheumatoid arthritis);
  • Asymptomatic OA of one or both knees.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Glauko Dantas

São Carlos, São Paulo, Brazil

Location

Related Publications (2)

  • Dantas G, Sacco ICN, Dos Santos AF, Watari R, Matias AB, Serrao PRMS, Pott-Junior H, Salvini TF. Effects of a foot-ankle strengthening programme on clinical aspects and gait biomechanics in people with knee osteoarthritis: protocol for a randomised controlled trial. BMJ Open. 2020 Sep 25;10(9):e039279. doi: 10.1136/bmjopen-2020-039279.

  • Dantas GAF, Sacco ICN, Ferrari AV, Matias AB, Watari R, Oliveira LVM, Marcon TR, Fatore JA, Pott-Junior H, Salvini TF. Effects of a foot-ankle muscle strengthening program on pain and function in individuals with knee osteoarthritis: a randomized controlled trial. Braz J Phys Ther. 2023 Jul-Aug;27(4):100531. doi: 10.1016/j.bjpt.2023.100531. Epub 2023 Aug 11.

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator (MSc)

Study Record Dates

First Submitted

October 31, 2019

First Posted

November 6, 2019

Study Start

January 27, 2020

Primary Completion

March 1, 2020

Study Completion

August 4, 2023

Last Updated

April 2, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will share

All data collected during the trial will be compiled electronically. Data integrity and validity will be verified at the time of data entry (edit checks). The project manager and research assistant will regularly monitor the study datasets and make recommendations regarding necessary protocol modifications or termination of all or part of the study. Participant data that underlie the results reported in this paper will be shared after blinding (text, tables, figures, appendices), immediately following publication. In addition, the study protocol and clinical trial report (both with the planned statistical analysis) will be made available by the researchers who proposed the methodology. Requests for data or any form of analysis should be directed to glauko.ft.andre@hotmail.com or tania@ufscar.br. Requesters will be asked to sign a data access agreement.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
Participant data that underlie the results reported in this paper will be shared after blinding (text, tables, figures, appendices), immediately following publication.
Access Criteria
Requests for data or any form of analysis should be directed to glauko.ft.andre@hotmail.com or tania@ufscar.br. Requesters will be asked to sign a data access agreement.

Locations